Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models

Por um escritor misterioso

Descrição

Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Functional redundancy between Apc and Apc2 regulates tissue
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Pygo and BCL9: the Wnt enhanceosome
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Expression of PYGO2 in prostate tumours revealed by
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Structural basis of the interaction between BCL9-Pygo and LDB-SSBP
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
TBX3 acts as tissue-specific component of the Wnt/β-catenin
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
TBX3 acts as tissue-specific component of the Wnt/β-catenin
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Parsing β-catenin's cell adhesion and Wnt signaling functions in
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Discovery of an Orally Bioavailable Small-Molecule Inhibitor for
de por adulto (o preço varia de acordo com o tamanho do grupo)